Hydrocortisone Hemisuccinate: 200 mg per day.

AUG 20, 2026 · PHASE 4 TRIAL

Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

ClinicalTrials.gov

This is a Phase 4 interventional trial registration with no results posted; the study is actively recruiting and has not yet reported outcomes, making it early-stage evidence.